04.01.09
FDA has appointed Frank Torti, MD, MPH, as principal deputy commissioner and new chief scientist. The newly created chief scientist position stems from the FDA Amendments Act of 2007. As chief scientist and a member of the agency’s senior leadership team, Dr. Torti will support the launch of the FDA Fellowship Program, which has the potential to attract up to 2000 professionals of varying disciplines for a two-year training program. The new office will work to ensure the quality and regulatory focus of the intramural research programs of the agency, and place special emphasis on the importance of clinical research trials that are a part of the foundation of FDA’s regulatory structure. Dr. Torti